Pulmonary embolism causes: Difference between revisions
mNo edit summary |
|||
| (29 intermediate revisions by 9 users not shown) | |||
| Line 6: | Line 6: | ||
|} | |} | ||
{{Pulmonary embolism}} | {{Pulmonary embolism}} | ||
{{ | {{CMG}} {{ATI}}; {{AE}} {{Ochuko}} | ||
==Overview== | ==Overview== | ||
| Line 26: | Line 26: | ||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
{|style="width:80%; height:100px" border="1" | {|style="width:80%; height:100px" border="1" | ||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | ||
| Line 44: | Line 43: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Asparaginase Erwinia chrysanthemi]],[[axitinib]], [[bevacizumab]], [[clomifene]], [[crizotinib]], [[desogestrel and ethinyl estradiol]], [[epirubicin ]], [[Estropipate]], [[Ethacrynic Acid]], [[ethynodiol diacetate and ethinyl estradiol]], [[etonogestrel]], [[fibrinogen]],[[glucocorticoids]], [[goserelin]], [[hormone replacement therapy]], [[idursulfase]], [[interferon gamma]], [[lenalidomide]], [[letrozole]], [[medroxyprogesterone]], [[meropenem]], [[oral contraceptives]], [[ospemifene]], [[palbociclib]], [[pergolide]], [[polidocanol]], [[pramipexole]], [[progesterone]], [[romidepsin]], [[tamoxifen]], [[testosterone]], [[thalidomide]], [[toremifene]], [[trametinib]], [[transdermal contraceptive]], [[vorinostat]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 156: | Line 155: | ||
*[[Corticobasal degeneration]] | *[[Corticobasal degeneration]] | ||
*[[Deep vein thrombosis]] | *[[Deep vein thrombosis]] | ||
*[[Desogestrel and Ethinyl Estradiol]] | |||
*[[Dyslipidemia]] | *[[Dyslipidemia]] | ||
*[[Ethynodiol diacetate and ethinyl estradiol]] | *[[Ethynodiol diacetate and ethinyl estradiol]] | ||
| Line 161: | Line 161: | ||
*[[Essential thrombocythemia]] | *[[Essential thrombocythemia]] | ||
*[[Essential thrombocytosis]] | *[[Essential thrombocytosis]] | ||
*[[Etonogestrel]] | |||
*[[Factor V Leiden mutation]] | *[[Factor V Leiden mutation]] | ||
*[[factor XII|Factor XII deficiency]] | *[[factor XII|Factor XII deficiency]] | ||
| Line 180: | Line 181: | ||
*[[Inflammatory bowel disease]] | *[[Inflammatory bowel disease]] | ||
*[[Injury]] | *[[Injury]] | ||
*[[Interferon gamma]] | |||
*[[Intravenous drug use]] | *[[Intravenous drug use]] | ||
*[[Lenalidomide]] | *[[Lenalidomide]] | ||
| Line 196: | Line 198: | ||
*[[Paget-Schroetter disease]] | *[[Paget-Schroetter disease]] | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Palbociclib]] | |||
*[[Pancreatic cancer]] | *[[Pancreatic cancer]] | ||
*[[Paroxysmal nocturnal hemoglobinuria]] | *[[Paroxysmal nocturnal hemoglobinuria]] | ||
*[[venous thrombosis|Pelvic vein thrombosis]] | *[[venous thrombosis|Pelvic vein thrombosis]] | ||
*[[Pergolide]] | |||
*[[plasminogen|Plasminogen deficiency]] | *[[plasminogen|Plasminogen deficiency]] | ||
*[[Polycystic ovary syndrome]] | *[[Polycystic ovary syndrome]] | ||
| Line 221: | Line 225: | ||
*[[Tuberculosis]] | *[[Tuberculosis]] | ||
*[[Vascular surgery]] | *[[Vascular surgery]] | ||
*[[Vorinostat]] | |||
{{col-end}} | {{col-end}} | ||
Latest revision as of 18:35, 7 June 2016
 |
Resident Survival Guide |
|
Pulmonary Embolism Microchapters |
|
Diagnosis |
|---|
|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
|
Treatment |
|
Follow-Up |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Pulmonary embolism causes On the Web |
|
Risk calculators and risk factors for Pulmonary embolism causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] The APEX Trial Investigators; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Overview
Pulmonary embolism (PE) is the acute obstruction of the pulmonary artery or one of its branches by a thrombus, air, tumor, or fat. Most often, PE is due to a venous thrombus which has been dislodged from its site of formation in the deep veins of the lower extremities, a process referred to as venous thromboembolism.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Pulmonary embolism is a life-threatening condition and must be treated as such irrespective of the underlying cause.
Common Causes
- The most common cause of PE is a venous thrombus which has been dislodged from its site of formation in the deep veins of the lower extremities.
- Non-thrombotic causes of PE are: